Mirati Therapeutics Investor Relations Material
Latest events
Q2 2023
Mirati Therapeutics
Access the full event backlog
Slides, Transcripts, and Reports from 13,000 public companies
Latest reports from Mirati Therapeutics Inc
Access all reports
Mirati Therapeutics Inc. is a clinical-stage biotechnology company focused on developing targeted cancer therapies. The company specializes in the research and development of treatments aimed at addressing genetic and epigenetic drivers of cancer. Mirati’s pipeline includes precision oncology candidates designed to inhibit specific molecular targets associated with tumor growth and progression. The company is headquartered in San Diego, California, and its shares are listed on the NASDAQ.
Latest articles
)
Eli Lilly: The Pharma Giant Behind Mounjaro and Zepbound
Eli Lilly's journey from insulin pioneer to global pharma giant, leading innovation in diabetes, obesity, and the future of metabolic health.
30 Jun 2025
)
500 Years of Craft, One Family Legacy: Beretta Holding's Global Expansion
How Beretta Holding managed to transform from a 16th-century gun barrel producer into a global industrial group while preserving 500 years of legacy.
27 Jun 2025
)
Shuntaro Furukawa: The Sixth President of Nintendo
Shuntaro Furukawa, Nintendo's sixth president, went from a childhood fan to leading the company through global expansion and the launch of Switch 2.
23 Jun 2025
Ticker symbol
MRTX
Country
🇺🇸 United States